ArticleQuantitative imaging in medicine and surgery2025
Fetal heart quantification ultrasound technology for the quantitative analysis of fetal cardiac morphology and function in hypertensive disorders of pregnancy.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Value of multimodal ultrasound assessment of placental dysfunction in gestational diabetes mellitus: a prospective study.Quantitative imaging in medicine and surgery · 2026Article
- Current status and prospects of prenatal ultrasound diagnosis of congenital heart disease in fetuses: a narrative review.Translational pediatrics · 2026Review
- Assessment of fetal cardiac structure and function in hyperthyroid pregnancies using fetal heart quantification technology.Quantitative imaging in medicine and surgery · 2026Article
- Assessment of fetal cardiac morphology and function in fetal growth restriction: insights from fetal heart quantification technology.Quantitative imaging in medicine and surgery · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertensive disorders of pregnancy (HDP) are associated with adverse outcomes for both the mother and fetus, including impaired fetal cardiac development and function. Accurate assessment of fetal heart morphology and function is essential for the early detection and management of potential complications. This study investigated the clinical application value of fetal heart quantification (Fetal HQ) technology in evaluating the cardiac morphology and function in fetuses from pregnancies affected by HDP. Methods: This prospective study examined 43 fetuses from singleton pregnancies complicated by HDP [mean gestational age (GA) 29.5±2.8 weeks] and 50 fetuses from normal pregnancies (mean GA 29.2±2.4 weeks). All participants underwent fetal ultrasonography from August 2023 to July 2024. Fetal HQ technology, incorporating two-dimensional speckle-tracking echocardiography (2D-STE) with quantitative analysis of cardiac segments, was used to assess heart size, shape, ventricular structure, contractility, and function. Results: The HDP group exhibited significantly altered maternal clinical characteristics, including higher maternal weight, BMI, and blood pressure. Fetal cardiac morphometry indicated that compared to the control group, the HDP group had larger left ventricular (LV) dimensions yet lower volumes but had smaller right ventricular (RV) dimensions. Notably, compared with the control group, the HDP group had a larger LV end-diastolic (ED) area (2.52±0.88 Conclusions: Fetal HQ technology effectively identified significant alterations in fetal heart structure and function in pregnancies complicated by HDP. These findings suggest that Fetal HQ is a useful tool for the early detection of fetal heart abnormalities and can facilitate timely intervention and accurate prognosis in affected pregnancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.